In general, tumour cell lines that can produce endogenous TNFα (~5-10% of cancer cell lines) are sensitive to SMCs alone, but pro-death cytokine ligands are often required for maximal SMC efficacy [8, 11, 12]. This evidence concerns the gene TNF and cancer.